(Q47441844)

16 January 2018

title

Plasma cytokine levels predict response to corticosteroids in septic shock (English)

1 reference

16 January 2018

0 references

1 reference

2

1 reference

16 January 2018

John H. Boyd

4

object named as

John Boyd

1 reference

16 January 2018

author name string

Peter Bentzer

1

1 reference

16 January 2018

Keith R Walley

3

1 reference

16 January 2018

James A Russell

5

1 reference

16 January 2018

publication date

12 April 2016

1 reference

16 January 2018

published in

Intensive Care Medicine

1 reference

16 January 2018

volume

42

1 reference

16 January 2018

issue

12

1 reference

16 January 2018

page(s)

1970-1979

1 reference

16 January 2018

Severe sepsis and septic shock

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Reduced cortisol metabolism during critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Cytokines and signaling molecules predict clinical outcomes in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Vasopressin versus norepinephrine infusion in patients with septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Optimal matching with a variable number of controls vs. a fixed number of controls for a cohort study trade-offs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

IL-6 as a keystone cytokine in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

B cells and professional APCs recruit regulatory T cells via CCL4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Admission chemokine (C-C motif) ligand 4 levels predict survival in pediatric septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Low-dose corticosteroid treatment in septic shock: a propensity-matching study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Clinical impact of stress dose steroids in patients with septic shock: insights from the PROWESS-Shock trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-016-4338-Z

Serum Cytokine Levels in Human Septic Shock

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27071387

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Steroids in the treatment of clinical septic shock

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27071387

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00134-016-4338-Z

1 reference

16 January 2018

1 reference

16 January 2018